Screening and Treatment of Bacterial Vaginosis During Pregnancy: A Model for Determining Benefit
| Autor: | Glantz Jc |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
medicine.medical_specialty
Cost-Benefit Analysis Pregnancy High-Risk Population Obstetric Labor Premature Obstetrics and gynaecology Pregnancy medicine Humans Mass Screening Pregnancy Complications Infectious education Mass screening Antibacterial agent Vaginitis education.field_of_study Obstetrics business.industry Incidence (epidemiology) Pregnancy Outcome Obstetrics and Gynecology Vaginosis Bacterial Models Theoretical medicine.disease Pediatrics Perinatology and Child Health Female Bacterial vaginosis business |
| Zdroj: | American Journal of Perinatology. 14:487-490 |
| ISSN: | 1098-8785 0735-1631 |
| DOI: | 10.1055/s-2007-994186 |
| Popis: | Bacterial vaginosis is associated with an increased risk of preterm birth. The treatment of bacterial vaginosis has recently been shown to decrease the risk of preterm delivery, especially in high-risk populations. However, the benefit of routine screening and treatment in the general population is uncertain. Using the information from several recent studies, a graph and nomogram generated from a mathematical model allow the obstetrician to determine the benefit of routine screening and treatment of bacterial vaginosis in his or her obstetrical population, depending on the prevalence of bacterial vaginosis and the total preterm delivery rate in that obstetrician's practice. If the prevalence of bacterial vaginosis and the incidence of preterm delivery are low, then routine screening would be expected to prevent small numbers of preterm births, and therefore may not be cost-effective. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|